PGT-A/PGT-M treatment aims to significantly improve the success rates of IVF cycles and prevent the inheritance of genetic disorders. By identifying genetically healthy embryos before implantation, it reduces the risk of miscarriage, increases the likelihood of a healthy pregnancy, and decreases the need for multiple IVF attempts. The technique involves a delicate biopsy of a few cells from the embryo's outer layer (trophectoderm), followed by sophisticated genetic analysis. DivinHeal facilitates access to world-class reproductive geneticists and fertility specialists who utilize the latest technology for precise and reliable testing.

Preimplantation Genetic Testing (PGT-A/PGT-M) is a complex, multi-step process integrated into an IVF cycle:
1. Ovarian Stimulation and Egg Retrieval: The female patient undergoes controlled ovarian stimulation to produce multiple eggs. These eggs are then retrieved through a minor surgical procedure.
2. Fertilization and Embryo Culture: The retrieved eggs are fertilized with sperm in the laboratory to create embryos. These embryos are then cultured for five to seven days until they reach the blastocyst stage.
3. Trophectoderm Biopsy: When embryos reach the blastocyst stage, a highly skilled embryologist performs a delicate biopsy. Using a laser, a small opening is created in the outer layer of the embryo (zona pellucida). A few cells (typically 5-10) are then carefully removed from the trophectoderm, which will eventually form the placenta, not the fetus itself.
4. Embryo Vitrification: After the biopsy, the biopsied embryos are immediately flash-frozen (vitrified) and stored, awaiting the genetic test results.
5. Genetic Analysis: The biopsied cells are sent to a specialized genetics laboratory. For PGT-A, the DNA from these cells is analyzed using techniques like Next-Generation Sequencing (NGS) to count chromosomes and identify aneuploidies. For PGT-M, specific DNA probes are used to test for the known single-gene disorder.
6. Reporting and Counseling: The laboratory generates a detailed report indicating the chromosomal status (for PGT-A) or genetic disease status (for PGT-M) of each embryo. A genetic counselor or fertility specialist discusses these results with the couple.
7. Frozen Embryo Transfer (FET): Once results are available, a single, genetically normal (euploid and/or disease-free) embryo is selected and transferred into the patient's uterus in a subsequent cycle.

Key Benefits of PGT-A/PGT-M Treatment

• Improved IVF Success Rates

  By identifying and transferring only euploid (chromosomally normal) embryos, PGT-A significantly increases the likelihood of successful implantation and live birth rates per embryo transfer.

• Reduced Risk of Miscarriage

  Aneuploidy is a major cause of early pregnancy loss. PGT-A helps to reduce the risk of miscarriage by identifying and avoiding the transfer of chromosomally abnormal embryos.

• Prevention of Genetic Disorders

  PGT-M offers hope to couples carrying genetic conditions by ensuring that only embryos free from the specific inherited disorder are transferred, preventing its transmission to their children.

• Decreased Time to Pregnancy

  By selecting the most viable embryos, PGT-A/PGT-M can reduce the number of IVF cycles required to achieve a successful pregnancy, both physically and emotionally.

• Reduced Multiple Pregnancies

  The high confidence in euploid embryos often allows for single embryo transfer (SET), minimizing the risks associated with multiple pregnancies for both mother and babies.

• Enhanced Peace of Mind

  Knowing that your transferred embryo has been screened for common chromosomal abnormalities or specific genetic diseases provides immense reassurance during a vulnerable time.

PGT-A/PGT-M Recovery Time and Tips

The 'recovery' associated with PGT-A/PGT-M primarily pertains to the IVF cycle itself and the emotional waiting period for results, rather than a significant physical recovery from the PGT procedure itself. The embryo biopsy is a laboratory procedure and does not directly impact the patient's physical recovery.

Physical Recovery (Post-IVF Procedures)

• Egg Retrieval: Patients will experience mild discomfort, bloating, or cramping for a few days after egg retrieval. Recovery tips include rest, staying hydrated, and avoiding strenuous activities.
• Embryo Transfer: After a frozen embryo transfer (FET) with a PGT-tested embryo, most patients can resume light activities within a day or two. There is typically no specific physical 'recovery' from the transfer itself.

Emotional Recovery & Waiting Period

The most significant aspect of 'recovery' with PGT-A/PGT-M is the emotional journey and the waiting period for genetic test results. This can be a time of heightened anxiety and anticipation. DivinHeal emphasizes comprehensive support throughout this phase:

• Support Systems: Lean on your partner, family, and friends. Many clinics offer support groups or connect you with counselors specializing in fertility.
• Mindfulness & Stress Reduction: Engage in gentle activities like meditation, yoga, or light walks. Focus on maintaining emotional well-being.
• Patience and Trust: The wait for results, typically 1-2 weeks, requires patience. Trust in the process and the expertise of your medical team.
• Healthy Lifestyle: Continue a balanced diet, adequate sleep, and avoid alcohol/smoking to create an optimal environment for potential pregnancy.

DivinHeal's dedicated care coordinators offer continuous reassurance and guidance, ensuring you feel supported at every step of your PGT-A/PGT-M journey, including managing the recovery period effectively.

Conditions Benefitting from PGT-A/PGT-M

• Patients with Advanced Maternal Age

  Women over 35 have a higher risk of producing eggs with chromosomal abnormalities, making PGT-A a crucial tool to identify euploid embryos.

• Recurrent Pregnancy Loss

  Couples experiencing multiple miscarriages often benefit from PGT-A to identify chromosomal imbalances in embryos that might be contributing to these losses.

• Multiple Failed IVF Cycles

  For individuals who have undergone several IVF cycles without success, PGT-A can help in selecting the most viable embryos, improving implantation rates.

• Known Carriers of Genetic Disorders (PGT-M)

  Couples where one or both partners carry a gene for a specific inherited condition (e.g., Cystic Fibrosis, Thalassemia, Sickle Cell Anemia, Huntington's disease) can use PGT-M to ensure only embryos free from the disorder are transferred.

• Structural Chromosomal Rearrangements (PGT-SR)

  Individuals with balanced translocations or inversions can utilize PGT-SR (a specific type of PGT) to identify embryos with a normal chromosomal complement, preventing severe genetic issues in offspring.

• Severe Male Factor Infertility

  In some cases, severe male factor infertility can be associated with an increased risk of aneuploidy in embryos, making PGT-A a beneficial adjunct.

Preparation for PGT-A/PGT-M involves the standard preparatory steps for an In Vitro Fertilization (IVF) cycle, as PGT is an adjunct to IVF:
1. Initial Consultation and Fertility Assessment: Comprehensive medical history review, physical examination, blood tests (hormone levels), and imaging (ultrasound) for both partners to assess fertility status.
2. Genetic Counseling: Mandatory counseling to discuss genetic risks, the implications of PGT-A/PGT-M, and to prepare for PGT-M, specific genetic probes may need to be developed in advance, which can take several weeks or months.
3. Ovarian Stimulation: The female partner undergoes a regimen of injectable fertility medications to stimulate the ovaries to produce multiple eggs. Regular monitoring with blood tests and ultrasound scans tracks follicle growth.
4. Egg Retrieval: Once follicles are mature, a minor outpatient surgical procedure is performed under sedation to retrieve the eggs from the ovaries.
5. Sperm Collection: On the day of egg retrieval, a sperm sample is collected from the male partner.
6. Fertilization: Eggs are fertilized with sperm in the laboratory, typically using Intracytoplasmic Sperm Injection (ICSI).
7. Embryo Culture: The fertilized eggs (embryos) are cultured for 5-7 days in the laboratory to reach the blastocyst stage, which is crucial for a successful and safe trophectoderm biopsy.

While PGT-A/PGT-M offers significant benefits, it's important to be aware of potential risks and limitations:
1. Embryo Damage: Although rare (less than 0.1-0.5%), there is a minimal risk of damaging the embryo during the biopsy procedure, which could prevent its development or implantation.
2. Misdiagnosis: No diagnostic test is 100% accurate. There's a small chance of false positive or false negative results, leading to the transfer of an aneuploid embryo or discarding a healthy one. This can be due to mosaicism (presence of both normal and abnormal cells in the embryo).
3. Mosaicism: Some embryos may contain a mix of chromosomally normal and abnormal cells (mosaicism). The interpretation of mosaic results can be complex, and deciding whether to transfer a mosaic embryo requires careful counseling.
4. No Embryos for Transfer: Due to the high rate of aneuploidy in human embryos, especially with advanced maternal age, PGT-A can result in no chromosomally normal embryos being identified for transfer, leading to emotional distress.
5. Cost: PGT-A/PGT-M adds significant cost to an IVF cycle, which may be prohibitive for some couples.
6. Ethical Considerations: Discussions around embryo selection and discard can raise ethical and moral dilemmas for some individuals.
7. Failure to Biopsy or Test: In some cases, embryos may not develop sufficiently for biopsy, or the genetic material obtained may be insufficient for analysis.

Your PGT-A/PGT-M Patient Journey with DivinHeal

• Initial Consultation & Genetic Counseling

  Your journey begins with a comprehensive consultation with an IVF specialist and a genetic counselor. This phase involves a thorough review of your medical history, fertility assessments, and genetic risk factors to determine the suitability and specific type of PGT (PGT-A or PGT-M).

• IVF Cycle & Embryo Development

  Following ovarian stimulation and egg retrieval, fertilization occurs in the lab. The resulting embryos are cultured for 5-7 days until they reach the blastocyst stage, which is optimal for biopsy.

• Embryo Biopsy & Genetic Analysis

  A highly skilled embryologist performs a delicate trophectoderm biopsy, extracting a few cells from each viable embryo. These cells are then sent to a specialized genetic laboratory for PGT-A/PGT-M analysis. Meanwhile, the embryos are cryopreserved (vitrified) awaiting results.

• Results & Embryo Transfer

  Once the genetic analysis is complete, a detailed report is shared, identifying chromosomally normal (euploid) or disease-free embryos. Based on these results, a single, healthy embryo is selected for transfer into the uterus, optimizing the chances of a successful pregnancy.

• Pregnancy & Follow-up

  Post-transfer, a pregnancy test is conducted. DivinHeal provides continuous support throughout your pregnancy and connects you with specialists for ongoing care, ensuring a smooth and reassuring experience from diagnosis to recovery.